BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8551616)

  • 1. Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.
    Bonneau AM; Kibler P; White P; Bousquet C; Dansereau N; Cordingley MG
    J Virol; 1996 Feb; 70(2):787-93. PubMed ID: 8551616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the molecular mechanism of viral resistance to peptidomimetic inhibitors of ribonucleotide reductase.
    White PW
    Biochim Biophys Acta; 1998 Jan; 1382(1):102-10. PubMed ID: 9507079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
    Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
    Lawetz C; Liuzzi M
    Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Grenier L; Llinas-Brunet M; Plante R
    J Med Chem; 1995 Sep; 38(18):3617-23. PubMed ID: 7658449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo.
    Liuzzi M; Déziel R; Moss N; Beaulieu P; Bonneau AM; Bousquet C; Chafouleas JG; Garneau M; Jaramillo J; Krogsrud RL
    Nature; 1994 Dec; 372(6507):695-8. PubMed ID: 7990963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit.
    Krogsrud RL; Welchner E; Scouten E; Liuzzi M
    Anal Biochem; 1993 Sep; 213(2):386-94. PubMed ID: 8238915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.
    Brandt CR; Spencer B; Imesch P; Garneau M; Déziel R
    Antimicrob Agents Chemother; 1996 May; 40(5):1078-84. PubMed ID: 8723444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of heterosubunit complexes formed by the R1 and R2 subunits of herpes simplex virus 1 and equine herpes virus 4 ribonucleotide reductase.
    Sun Y; Conner J
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):97-104. PubMed ID: 10727407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligopeptide inhibition of class I ribonucleotide reductases.
    Cooperman BS
    Biopolymers; 2003; 71(2):117-31. PubMed ID: 12767114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity of synthetic peptides for the HSV-2 ribonucleotide reductase R1 subunit measured with an iodinated photoaffinity peptide.
    Lamarche N; Gaudreau P; Massie B; Langelier Y
    Anal Biochem; 1994 Aug; 220(2):315-20. PubMed ID: 7978273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
    Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
    J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Garneau M; Gauthier J; Ghiro E; Goulet S; Guse I; Jaramillo J; Llinas-Brunet M; Malenfant E; Plante R; Poirier M; Soucy F; Wernic D; Yoakim C; Déziel R
    J Med Chem; 1996 Oct; 39(21):4173-80. PubMed ID: 8863795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase.
    Liuzzi M; Kibler P; Bousquet C; Harji F; Bolger G; Garneau M; Lapeyre N; McCollum RS; Faucher AM; Simoneau B; Cordingley MG
    Antiviral Res; 2004 Dec; 64(3):161-70. PubMed ID: 15550269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth.
    Smith CC; Peng T; Kulka M; Aurelian L
    J Virol; 1998 Nov; 72(11):9131-41. PubMed ID: 9765459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic characterization of clinical isolates of herpes simplex virus resistant to aciclovir.
    Harris W; Collins P; Fenton RJ; Snowden W; Sowa M; Darby G
    J Gen Virol; 2003 Jun; 84(Pt 6):1393-1401. PubMed ID: 12771406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection.
    Bridges CG; Ahmed SP; Sunkara PS; McCarthy JR; Tyms AS
    Antiviral Res; 1995 Aug; 27(4):325-34. PubMed ID: 8540753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains.
    Kudo E; Shiota H; Naito T; Satake K; Itakura M
    J Med Virol; 1998 Oct; 56(2):151-8. PubMed ID: 9746072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
    Saijo M; Suzutani T; Morikawa S; Kurane I
    Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.